Alteration of erythrocyte membrane polyunsaturated fatty acids in preterm newborns with retinopathy of prematurity

Autor: Stéphane Grégoire, Niyazi Acar, Denis S. Semama, Julie Mazzocco, Ninon Ternoy, Charlotte Pallot, Cyril Meillon, Lionel Bretillon, Catherine Creuzot-Garcher, Corinne Chantegret, Alain M. Bron, Delphine Martin, Aurélie Donier
Přispěvatelé: Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), Centre des Sciences du Goût et de l'Alimentation [Dijon] (CSGA), Centre National de la Recherche Scientifique (CNRS)-AgroSup Dijon - Institut National Supérieur des Sciences Agronomiques, de l'Alimentation et de l'Environnement-Institut National de la Recherche Agronomique (INRA)-Université de Bourgogne (UB), Université Bourgogne Franche-Comté [COMUE] (UBFC), This work has been funded by the Regional Council of Burgundy France (PARI Agral 1), FEDER (European Funding for Regional Economical Development), Association Nationale Recherche Technologie, Fondation de France/Fondation de l’Oeil, Agence Nationale de la Recherche [ANR-11-LABEX-0021]., Acar, Niyazi
Rok vydání: 2019
Předmět:
0301 basic medicine
Organes des sens
prémature
lcsh:Medicine
fatty acids
retinopathy of prematury
chemistry.chemical_compound
0302 clinical medicine
Prospective Studies
lcsh:Science
Prospective cohort study
chemistry.chemical_classification
Multidisciplinary
Gestational age
Retinopathy of prematurity
3. Good health
Docosahexaenoic acid
In utero
Alimentation et Nutrition
Fatty Acids
Unsaturated

Female
lipids (amino acids
peptides
and proteins)

Arachidonic acid
Animal studies
Infant
Premature

Polyunsaturated fatty acid
medicine.medical_specialty
rétine
Sensory Organs
Médecine humaine et pathologie
Gestational Age
Article
03 medical and health sciences
Fatty Acids
Omega-6

Internal medicine
Fatty Acids
Omega-3

medicine
Food and Nutrition
Humans
[SDV.MHEP.OS]Life Sciences [q-bio]/Human health and pathology/Sensory Organs
Fatty acids
acide gras oméga 6
business.industry
lcsh:R
Erythrocyte Membrane
Infant
Newborn

acide gras oméga 3
medicine.disease
eye diseases
030104 developmental biology
Endocrinology
chemistry
lcsh:Q
Human health and pathology
business
[SDV.AEN]Life Sciences [q-bio]/Food and Nutrition
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
030217 neurology & neurosurgery
Zdroj: Scientific Reports
Scientific Reports, Nature Publishing Group, 2019, 9 (1), pp.7930. ⟨10.1038/s41598-019-44476-w⟩
Scientific Reports 1 (9), 7930. (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-10 (2019)
ISSN: 2045-2322
Popis: Extremely preterm infants are at high risk for retinopathy of prematurity (ROP), a potentially blinding disease characterized by abnormalities in retinal vascularization. Whereas animal studies revealed that n-3 polyunsaturated fatty acids (PUFAs) may be of benefit in preventing ROP, human studies conducted on preterm infants during the 1st weeks of life showed no association between blood n-3 PUFA bioavailability and ROP incidence and/or severity, probably because of the influence of nutrition on the lipid status of infants. In the OmegaROP prospective cohort study, we characterized the erythrocyte concentrations of PUFAs in preterm infants aged less than 29 weeks gestational age (GA) without any nutritional influence. We show that GA is positively associated with the erythrocyte n-6 to n-3 PUFA ratio, and particularly with the ratio of arachidonic acid (AA) to docosahexaenoic acid (DHA), in infants with ROP. A time-dependent accumulation of AA at the expense of DHA seems to occur in utero in erythrocytes of preterm infants who will develop ROP, thus reinforcing previous data on the beneficial properties of DHA on this disease. In addition, preliminary data on maternal erythrocyte membrane lipid concentrations suggest modifications in placental transfer of fatty acids. Documenting the erythrocyte AA to DHA ratio at birth in larger cohorts might be useful to set up new prognostic factors for ROP.
Databáze: OpenAIRE